Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Athersys: Activating gene expression

If necessity is the mother of invention, Athersys Inc. is twice born. The company was founded on the basis of human microchromosome technology it believed was necessary for gene therapy applications, but has since developed a gene expression platform technology that it believes is necessary for high-throughput drug discovery and protein production.

While gene therapy has not yet caught up to microchromosomes as vectors, the

Read the full 642 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers